Solid Biosciences Inc

SLDB

Healthcare|Biotechnology|USA

$10.40

-0.71 (-6.38%)

Tangible Book

$3.80

Earnings Power

$3.33

Upcoming Data Readouts (5)

Oct 2026

Est. completion

P1P2Duchenne Muscular Dystrophy

Microdystrophin Gene Transfer Study in Adolescents and Children With DMD

May 2027

Est. completion

P1P2Duchenne Muscular Dystrophy

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

Jun 2027

Est. completion

P1Catecholaminergic Polymorphic Ventricular Tachycardia

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Mar 2028

Est. completion

P1Friedreich's Ataxia (FA)

A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

Jan 2029

Est. completion

P3Duchenne Muscular Dystrophy

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)